Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Oncology Institute (TOI) Shares Outstanding (Weighted Average) (2020 - 2025)

Historic Shares Outstanding (Weighted Average) for Oncology Institute (TOI) over the last 6 years, with Q3 2025 value amounting to $97.5 million.

  • Oncology Institute's Shares Outstanding (Weighted Average) rose 2906.33% to $97.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $97.5 million, marking a year-over-year increase of 2906.33%. This contributed to the annual value of $75.0 million for FY2024, which is 175.6% up from last year.
  • According to the latest figures from Q3 2025, Oncology Institute's Shares Outstanding (Weighted Average) is $97.5 million, which was up 2906.33% from $93.2 million recorded in Q2 2025.
  • Oncology Institute's Shares Outstanding (Weighted Average)'s 5-year high stood at $97.5 million during Q3 2025, with a 5-year trough of $62.9 million in Q1 2021.
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $73.7 million (2023), whereas its average is $74.5 million.
  • In the last 5 years, Oncology Institute's Shares Outstanding (Weighted Average) soared by 18705.14% in 2021 and then grew by 26.86% in 2023.
  • Oncology Institute's Shares Outstanding (Weighted Average) (Quarter) stood at $66.2 million in 2021, then increased by 9.91% to $72.8 million in 2022, then increased by 1.31% to $73.7 million in 2023, then grew by 1.76% to $75.0 million in 2024, then grew by 29.89% to $97.5 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $97.5 million for Q3 2025, versus $93.2 million for Q2 2025 and $77.1 million for Q1 2025.